Skye Bioscience board approves amended inducement equity plan with broader change-in-control authority

Skye Bioscience, Inc.

Amendment gives administrator broader authority to cancel, assume, accelerate, or cash out outstanding awards upon a Change in Control.
Total shares authorized under the plan remain 600,000; no change to share pool.
Plan is used for inducement grants to new employees; all awards must be approved by a majority of independent directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.